Vimarsana
Biggest News Aggregation in the World

Admp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Admp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Admp Today - Breaking & Trending Today

Domino's Pizza Enterprises Limited (ASX:DMP) to Issue Interim Dividend of $0.56 - Vimarsana News

Domino's Pizza Enterprises Limited (ASX:DMP) to Issue Interim Dividend of $0.56

Domino’s Pizza Enterprises Limited (ASX:DMP – Get Free Report) announced a interim dividend on Friday, February 23rd, MarketIndexAU reports. Investors of record on Tuesday, March 26th will be given a dividend of 0.555 per share on Tuesday, March 26th. This represents a yield of 1.28%. The ex-dividend date is Sunday, February 25th. Domino’s Pizza Enterprises […]

Half of 2,146 polling centres in Dhaka are risky, police say - Vimarsana News

Half of 2,146 polling centres in Dhaka are risky, police say

The BGB will work alongside the police and Ansar to patrol the polling stations

Statewide prescription drug monitoring program takes effect - Vimarsana News

Statewide prescription drug monitoring program takes effect

Missouri was the last state to implement a prescription drug monitoring program, which launched Dec. 13.

Adamis Pharmaceuticals (NASDAQ:ADMP) Earns Sell Rating from Analysts at StockNews.com - Vimarsana News

Adamis Pharmaceuticals (NASDAQ:ADMP) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Adamis Pharmaceuticals (NASDAQ:ADMP – Free Report) in a report issued on Wednesday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Adamis Pharmaceuticals Price Performance Adamis Pharmaceuticals has a 1 year low of $0.75 and a 1 year high of $26.18. The firm’s 50 day […]

StockNews.com Begins Coverage on Adamis Pharmaceuticals (NASDAQ:ADMP) - Vimarsana News

StockNews.com Begins Coverage on Adamis Pharmaceuticals (NASDAQ:ADMP)

StockNews.com assumed coverage on shares of Adamis Pharmaceuticals (NASDAQ:ADMP – Free Report) in a research report sent to investors on Tuesday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Adamis Pharmaceuticals Stock Performance The stock has a fifty day moving average price of $1.33 and a two-hundred day moving average […]

Source: wkrb13.com